Back to search

Use of Yeast-Secreted In vivo Biotinylated Recombinant Antibodies (Biobodies) in Bead-Based ELISA

Data up to Jan 2025

Published2008
Citations28
References30

Total Citations Per Year

Abstract

References (30)

Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach

1988 • 19,163 citations

An Introduction to Statistical Methods and Data Analysis

1994 • 5,244 citations

A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer

1983 • 2,102 citations

The area above the ordinal dominance graph and the area below the receiver operating characteristic graph

1975 • 1,423 citations

Multiplexed particle-based flow cytometric assays

2000 • 902 citations

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.

1996 • 692 citations

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

2003 • 690 citations

Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian Carcinomas

2005 • 557 citations

Mesothelin-family proteins and diagnosis of mesothelioma

2003 • 533 citations

Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library

2003 • 496 citations

New tumor markers: CA125 and beyond

2005 • 457 citations

Comparative hybridization of an array of 21 500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas

1999 • 398 citations

Potential markers that complement expression of CA125 in epithelial ovarian cancer

2005 • 357 citations

Lessons from BRCA: The Tubal Fimbria Emerges as an Origin for Pelvic Serous Cancer

2007 • 343 citations

Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma

1999 • 322 citations

Detection and Quantitation of Serum Mesothelin, a Tumor Marker for Patients with Mesothelioma and Ovarian Cancer

2006 • 280 citations

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma

2004 • 188 citations

Bead-Based ELISA for Validation of Ovarian Cancer Early Detection Markers

2006 • 142 citations

Multiplexed Analysis of Human Cytokines by Use of the FlowMetrix System

1998 • 142 citations

Mesothelin Variant 1 Is Released from Tumor Cells as a Diagnostic Marker

2006 • 108 citations

Linear Regression and Correlation

2009 • 106 citations

Ovarian cancer screening

2003 • 83 citations

Expression of candidate tumor markers in ovarian carcinoma and benign ovary: Evidence for a link between epithelial phenotype and neoplasia

2004 • 70 citations

Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery

2006 • 66 citations

Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/Mesothelin-dependent cell attachment

2007 • 62 citations

Method for generation of in vivo biotinylated recombinant antibodies by yeast mating

2006 • 47 citations

Changes in cancer worry associated with participation in ovarian cancer screening

2007 • 47 citations

GPI-specific phospholipase D mRNA expression in tumor cells of different malignancy.

2002 • 19 citations

Compliance of Average- and Intermediate-Risk Women to Semiannual Ovarian Cancer Screening

2004 • 19 citations

Comparing adaptive and non-adaptive algorithms for cancer early detection with novel biomarkers

2006 • 7 citations

Cited By (0)

No citing papers found in database

Use of Yeast-Secreted In vivo Biotinylated Recombinant Antibodies (Biobodies) in… (2008) – Clinical Cancer Research | Metascience Observatory Explorer